Israel’s NUVO has partnered with Jerusalem’s Hadassah hospital to develop an AI platform for accurate decision-making about pregnancy complications. NUVO has also just received US FDA approval for its INVU device (reported here previously) to be used in monitoring maternal fetal heart rate.

https://www.prnewswire.com/news-releases/nuvo-group-announces-partnership-with-hadassah-hebrew-university-medical-center-to-develop-innovative-pregnancy-population-management-platform-301058487.html